| 拜复乐治疗社区获得性肺炎68例疗效分析 |
| |
| 引用本文： | 廖鸥飞 李卓庶. 拜复乐治疗社区获得性肺炎68例疗效分析[J]. 基层医学论坛, 2007, 11(4): 301-302 |
| |
| 作者姓名： | 廖鸥飞 李卓庶 |
| |
| 作者单位： | 化州市人民医院,广东化州525100 |
| |
| 摘 要： | 目的评价分析拜复乐治疗社区获得性肺炎的疗效。方法对68例社区获得性肺炎患者，予拜复乐“莫西沙星”（德国拜耳公司）400mg，静脉滴注，每日1次，疗程7d～10d.结果临床有效率为92．7％，细菌清除率为85．5％，药物不良反应发生率为4．4％。结论拜复乐安全有效，是目前治疗社区获得性肺炎的理想药物。
|
| 关 键 词： | 莫西沙星 社区获得性肺炎 疗效 拜复乐 |
| 收稿时间： | 2006-11-24 |
Effection of Moxifloxacin on 68 cases of community-acquired pneumonia |
| |
| Liao Oufei, Li Zhouzhe. Effection of Moxifloxacin on 68 cases of community-acquired pneumonia[J]. Public Medical Forum Magazine, 2007, 11(4): 301-302 |
| |
| Authors: | Liao Oufei Li Zhouzhe |
| |
| Abstract: | Objective To evaluated the efficacy of moxifloxacin on community-acquired pneumonia. Methods 68 patients with community-acquired pneumonia were given moxifloxaein 400mg by intravenous infusion Qd. All patients had been treated for 7-14 days. Results The overall clinical effective rate was 92.7% and the bacterium clearante rate was 85.5%. The adverse effect incidence rate was 4.4%. Conclusion Moxifloxacin intravenous infusion is effective and safe for community-acquired pneumonia. |
| |
| Keywords: | Moxifloxacin Community-acquired pneumonia Curative effect |
| 本文献已被 维普 等数据库收录！ |
